Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

34 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Does quality of life of COPD patients as measured by the generic EuroQol five-dimension questionnaire differentiate between COPD severity stages?
Rutten-van Mölken MP, Oostenbrink JB, Tashkin DP, Burkhart D, Monz BU. Rutten-van Mölken MP, et al. Among authors: monz bu. Chest. 2006 Oct;130(4):1117-28. doi: 10.1378/chest.130.4.1117. Chest. 2006. PMID: 17035446 Clinical Trial.
Patient characteristics associated with quality of life in European women seeking treatment for urinary incontinence: results from PURE.
Monz B, Chartier-Kastler E, Hampel C, Samsioe G, Hunskaar S, Espuna-Pons M, Wagg A, Quail D, Castro R, Chinn C. Monz B, et al. Eur Urol. 2007 Apr;51(4):1073-81; discussion 1081-2. doi: 10.1016/j.eururo.2006.09.022. Epub 2006 Oct 11. Eur Urol. 2007. PMID: 17081676
Modelling the 5-year cost effectiveness of tiotropium, salmeterol and ipratropium for the treatment of chronic obstructive pulmonary disease in Spain.
Rutten-van Mölken MP, Oostenbrink JB, Miravitlles M, Monz BU. Rutten-van Mölken MP, et al. Among authors: monz bu. Eur J Health Econ. 2007 Jun;8(2):123-35. doi: 10.1007/s10198-007-0039-4. Epub 2007 Mar 17. Eur J Health Econ. 2007. PMID: 17370096 Free PMC article. Clinical Trial.
Probabilistic Markov model to assess the cost-effectiveness of bronchodilator therapy in COPD patients in different countries.
Oostenbrink JB, Rutten-van Mölken MP, Monz BU, FitzGerald JM. Oostenbrink JB, et al. Among authors: monz bu. Value Health. 2005 Jan-Feb;8(1):32-46. doi: 10.1111/j.1524-4733.2005.03086.x. Value Health. 2005. PMID: 15841892
Cost-effectiveness of tiotropium versus salmeterol: the POET-COPD trial.
Hoogendoorn M, Al MJ, Beeh KM, Bowles D, Graf von der Schulenburg JM, Lungershausen J, Monz BU, Schmidt H, Vogelmeier C, Rutten-van Mölken MP. Hoogendoorn M, et al. Among authors: monz bu. Eur Respir J. 2013 Mar;41(3):556-64. doi: 10.1183/09031936.00027212. Epub 2012 Jun 14. Eur Respir J. 2013. PMID: 22700844 Clinical Trial.
Adjusting for COPD severity in database research: developing and validating an algorithm.
Goossens LM, Baker CL, Monz BU, Zou KH, Rutten-van Mölken MP. Goossens LM, et al. Among authors: monz bu. Int J Chron Obstruct Pulmon Dis. 2011;6:669-78. doi: 10.2147/COPD.S26214. Epub 2011 Dec 6. Int J Chron Obstruct Pulmon Dis. 2011. PMID: 22259243 Free PMC article.
Is the EQ-5D responsive to recovery from a moderate COPD exacerbation?
Goossens LM, Nivens MC, Sachs P, Monz BU, Rutten-van Mölken MP. Goossens LM, et al. Among authors: monz bu. Respir Med. 2011 Aug;105(8):1195-202. doi: 10.1016/j.rmed.2011.02.018. Epub 2011 Mar 24. Respir Med. 2011. PMID: 21439807
Responsiveness of the cough and sputum assessment questionnaire in exacerbations of COPD and chronic bronchitis.
Monz BU, Sachs P, McDonald J, Crawford B, Nivens MC, Tetzlaff K. Monz BU, et al. Respir Med. 2010 Apr;104(4):534-41. doi: 10.1016/j.rmed.2009.10.026. Epub 2009 Nov 14. Respir Med. 2010. PMID: 19917525
Development and validation of a cough and sputum assessment questionnaire.
Crawford B, Monz B, Hohlfeld J, Roche N, Rubin B, Magnussen H, Nivens C, Ghafouri M, McDonald J, Tetzlaff K. Crawford B, et al. Respir Med. 2008 Nov;102(11):1545-55. doi: 10.1016/j.rmed.2008.06.009. Epub 2008 Jul 27. Respir Med. 2008. PMID: 18662868
Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence.
Mauskopf JA, Baker CL, Monz BU, Juniper MD. Mauskopf JA, et al. Among authors: monz bu. J Med Econ. 2010;13(3):403-17. doi: 10.3111/13696998.2010.499813. J Med Econ. 2010. PMID: 20608887 Review.
34 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback